Methamphetamine Abuse
Conditions
Keywords
Methamphetamine patients, Cognitive impairments, tACS
Brief summary
1. To evaluate the cognitive function of methamphetamine Patients. 2. Investigate the pathological mechanism of methamphetamine patients from the aspects of EEG and biology; 3. The investigators investigated the effects of transcranial alternating current stimulation (tACS) on cognitive impairments in methamphetamine patients
Interventions
DEVICETheta treatment group
The target 'active' electrode was placed over the MFC and the second 'return' electrode was placed over the medial parietal cortex. 6 Hz stimulation was used and a alternating current of 2mA was applied for 30min each day(Monday-Friday) for 3consecutive weeks
DEVICESham control group
Sham stimulation lasted 30 s (15 s of ramp- up and 15 s of ramp-down).
Sponsors
Beijing HuiLongGuan Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
MALE
Age
18 Years to 55 Years
Healthy volunteers
Yes
Inclusion criteria
* Clinical diagnosis diagnosis of methamphetamine use disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) * None of participants had mixed use of other drugs * None of participants had physical disability * None of participants had acute physical or mental illness, hallucinations, acute withdrawal symptoms * None of participants were receiving any medical treatment
Exclusion criteria
* Intracranial hypertension * Cranial defects * Tumors * Serious physical illnesses (e.g., cardiovascular, liver, kidney, gastrointestinal disorders) * Infectious diseases * Immune system disorders
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) | Baseline, week 3 | The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), which contains 12 subtests for calculating the index scores of delayed memory (including list recall, story recall, figure recall, and list recognition tests), attention (including digit span and coding tests), language (including picture naming and semantic fluency tests), visuospatial/constructional index (including figure copy and line orientation tasks), immediate memory (including list learning and story memory tasks), and global neuropsychological function. |
| ERP components associated with cognitive function | Baseline, week 3 | Investigate the ERP components associated with cognitive function of methamphetamine patients using event-related potential analysis |
| Condition stop signal task | Baseline, week 3 | Condition stop signal task was used to assess cognitive control function, including proactive control and reactive control. |
| Neural oscillations associated with cognitive function | Baseline, week 3 | Investigate the neural oscillations associated with cognitive function of methamphetamine patients using time-frequency analysis. |
| Functional connection of brain region associated with cognitive function | Baseline, week 3 | Investigate the functional connection of brain region associated with cognitive function of methamphetamine patients using functional connection analysis |
| Microstate associated with cognitive function | Baseline, week 3 | Investigate the microstate associated with cognitive function of methamphetamine patients using microstate analysis |
| Neural Dynamic Coding of brain region associated with cognitive function | baseline, week 3 | Investigate the functional connection of brain region associated with cognitive function of methamphetamine patients using multivariate pattern analysis |
| The effect of oxidative stress system on cognitive function | Baseline, week 3 | The investigators examined markers of oxidative stress related to cognitive function using bioassay. |
| The effect of immune system on cognitive function | Baseline, week 3 | The investigators immune indicators related to cognitive function using bioassay. |
| The effect of brain derived neurotrophic factor(BDNF) on cognitive function | Baseline, week 3 | The investigators BDNF indicators related to cognitive function using bioassay. |
| Genetic mechanism of cognitive function | Baseline, week 3 | The investigators performed comprehensive genetic testing to explore the genetic mechanism of cognitive function. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Rumination Questionnaire | Baseline, week 3 | Rumination Questionnaire was used to access ruminate behavior.A higher total score indicates a higher tendency to ruminate. The total score varies between 22 and 88 points, with higher scores indicating higher tendency to ruminate. |
| Anger Rumination Questionnaire | Baseline, week 3 | Anger Rumination Questionnaire was used to access anger ruminate behavior. The total score varies between 19 and 76 points, with higher scores indicating higher tendency to anger ruminate. |
| Reverse learning task | Baseline, week 3 | Reverse learning task was used to access the compulsive drug using behavior of methamphetamine patients. |
| Emotional Regulation Difficulty Scale | Baseline, week 3 | Emotional Regulation Difficulty Scale was used to access the emotional regulation ability of methamphetamine patients.The total score varies between 36 and 180 points, with higher scores indicating the more serious the difficulty in emotion regulation and the lower the level of emotion regulation ability. |
| Aggressive questionnair | Baseline, week 3 | Aggressive questionnaire was used to access aggressive behavior of methamphetamine patients. The total score varies between 30 and 150 points, with higher scores indicating the more aggressive behavior. |
| Beck Anxiety Scale | Baseline, week 3 | Beck Anxiety Scale was used to access degree of anxiety.The total score varies between 0 and 63 points, with higher scores indicating higher levels of anxiety. |
| Beck Depression Scale | Baseline, week 3 | Beck Depression Scale was used to access degree of depression.The total score varies between 0 and 30 points, with higher scores indicating higher levels of depression. |
| Barrett impulse Scale | Baseline, week 3 | The scale includes three dimensions: motor impulsivity, cognitive impulsivity and unplanned impulsivity. The total score varies between 30 and 150 points, with higher scores indicating higher levels of impulsivity. High scores on the three subscales indicated hyperactivity, inattention, and lack of planning, respectively. |
| Degree of insomnia | Baseline, week 3 | Insomnia Severity Index was used acess the patient's insomnia.The total score varies between 0 and 28 points, with higher scores indicating higher levels of insomnia. |
| The Sensitivity to Punishment and Reward Questionnaire | Baseline, week 3 | The Sensitivity to Punishment and Reward Questionnaire including penalty sensitivity factor and reward sensitivity factor. The total score varies between 0 and 31 points, with higher scores indicating higher sensitivity to penalty and reward. |
| Visual analog scale | Baseline, week 3 | Visual analog scale（VAS） was used to acess the craving of drug on a scale of 1 to 10.A higher score indicates a higher desire for the drug |
| The Desires for Drug Questionnaire | Baseline, week 3 | The Desires for Drug Questionnaire (DDQ) was used to access the craving of drug, which measures three factors, including desire and intention, negative reinforcement, and control. Higher scores of drug desire and negative reinforcement indicated higher drug craving, and higher scores of control indicated better drug craving control ability.The total score on the table is equal to the sum of the scores in the three dimensions, ranging from 3 to 21 points. |
| Obsessive compulsive drug use scale | Baseline, week 3 | The Obsessive Compulsive Drug Use Scale (OCDUS) also measures three factors: thoughts about methamphetamine and interference, desire and control, and resistance to thoughts and intention.The higher the total score, the higher the craving. The total score varies between 13 and 65 points, with higher scores indicating higher craving. |
| Obsessive-compulsive inventory | Baseline, week 3 | Obsessive-compulsive inventory was evaluated the subjects' obsessive-compulsive symptoms from 6 different dimensions, including washing, forcing thoughts, storing, sorting, checking, mixing.The total score varies between 0 and 72 points, with higher scores indicating more severe obsessive-compulsive symptoms. |
| Thought Control Ability Questionnaire | Baseline, week 3 | Thought Control Ability Questionnaire was used to measure the ability of an individual to control unwanted and intrusive thoughts. The total score varies between 25 and 125 points, with higher indicating scores the stronger the thought control ability. |
| Thought Suppression Questionnaire | Baseline, week 3 | Thought Suppression Questionnaire were used to access the thought control ability. The total score varies between 15 and 75 points, with higher indicating scores the stronger the thought suppression ability. |
Countries
China
Outcome results
None listed